Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Brainstorm Cell Therapeutics Inc. (BCLI) had Return on Investments of 33.24% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.85M |
|
-- |
|
-- |
|
$3.61M |
|
$-3.61M |
|
$-0.24M |
|
$-3.85M |
|
$-3.85M |
|
$-3.85M |
|
$-3.85M |
|
$-3.85M |
|
$-3.85M |
|
$-3.61M |
|
$-3.57M |
|
11.04M |
|
11.04M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$0.32M |
|
$0.15M |
|
$0.47M |
|
$0.79M |
|
$12.38M |
|
-- |
|
-- |
|
$12.38M |
|
$-11.60M |
|
$-11.60M |
|
$-11.60M |
|
11.04M |
|
| Cash Flow Statement Financials | |
$-2.21M |
|
$0.00M |
|
$2.15M |
|
$0.28M |
|
$0.21M |
|
$-0.07M |
|
$2.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-- |
|
-0.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
33.24% |
|
33.24% |
|
-489.21% |
|
|
Return on Investments |
33.24% |
$-1.05 |
|
$-0.20 |
|
$-0.20 |
|